[go: up one dir, main page]

AR054133A1 - Preparacion recubierta con azucar - Google Patents

Preparacion recubierta con azucar

Info

Publication number
AR054133A1
AR054133A1 ARP060102421A ARP060102421A AR054133A1 AR 054133 A1 AR054133 A1 AR 054133A1 AR P060102421 A ARP060102421 A AR P060102421A AR P060102421 A ARP060102421 A AR P060102421A AR 054133 A1 AR054133 A1 AR 054133A1
Authority
AR
Argentina
Prior art keywords
sugar
oxygen
active ingredient
preparation
preparation according
Prior art date
Application number
ARP060102421A
Other languages
English (en)
Inventor
Y Uchiyama
Y Nakano
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37498554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054133(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of AR054133A1 publication Critical patent/AR054133A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee una preparacion en donde un ingrediente activo inestable al oxígeno es estabilizada por recubrimiento de una parte que contiene el ingrediente activo inestable al oxígeno con una capa de recubrimiento con azucar que contiene (1) alcohol de azucar como material base de recubrimiento con azucar y (2) un aglutinante. Reivindicacion 2: La preparacion de acuerdo con la reivindicacion 1, caracterizada porque el alcohol de azucar es uno o más de uno seleccionado entre eritritol, manitol, xilitol y sorbitol. Reivindicacion 5: La preparacion de acuerdo con la reivindicacion 1, caracterizada porque el aglutinante es goma arábiga. Reivindicacion 8: La preparacion de acuerdo con la reivindicacion 1, caracterizada porque el ingrediente activo inestable al oxígeno es (R)-5,6-dimetoxi-2-[2,2,46,7-pentametil-3-(4-metilfenil)-2,3-dihidro-1-benzofuran-5-il]isoindolina.
ARP060102421A 2005-06-10 2006-06-09 Preparacion recubierta con azucar AR054133A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005171443 2005-06-10

Publications (1)

Publication Number Publication Date
AR054133A1 true AR054133A1 (es) 2007-06-06

Family

ID=37498554

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102421A AR054133A1 (es) 2005-06-10 2006-06-09 Preparacion recubierta con azucar

Country Status (19)

Country Link
US (1) US20090030064A1 (es)
EP (1) EP1889611A1 (es)
JP (1) JPWO2006132360A1 (es)
KR (1) KR20080014014A (es)
CN (1) CN101193625A (es)
AR (1) AR054133A1 (es)
AU (1) AU2006256038A1 (es)
BR (1) BRPI0611058A2 (es)
CA (1) CA2610342A1 (es)
CR (1) CR9523A (es)
IL (1) IL187407A0 (es)
MA (1) MA29540B1 (es)
NO (1) NO20080175L (es)
NZ (1) NZ563820A (es)
PE (1) PE20070077A1 (es)
RU (1) RU2407515C2 (es)
TW (1) TW200716207A (es)
WO (1) WO2006132360A1 (es)
ZA (1) ZA200710333B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673353B2 (en) 2008-02-11 2014-03-18 Dainippon Sumitomo Pharma Co., Ltd Tablet having improved elution properties
TW201021832A (en) * 2008-09-30 2010-06-16 Astellas Pharma Inc Pharmaceutical composition for oral administration
SI2474582T1 (en) * 2009-09-02 2018-01-31 Nippon Soda Co., Ltd. A coating agent comprising hydroxyalkyl cellulose
CN101804042A (zh) * 2010-04-16 2010-08-18 山东新华制药股份有限公司 普拉格雷片剂的制备方法
US10251194B2 (en) * 2013-06-17 2019-04-02 Nxp Usa, Inc. Efficient scheduling in asynchronous contention-based system
FR3013186B1 (fr) * 2013-11-19 2019-07-19 Roquette Freres Nouveaux snacks non allergenes contenant des proteines vegetales
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
FR3067567B1 (fr) * 2017-06-19 2019-07-05 Roquette Freres Nouveau procede de drageification et formes solides drageifiees presentant des formes irregulieres
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
JP7503420B2 (ja) * 2020-05-18 2024-06-20 東和薬品株式会社 フィンゴリモドを含む医薬組成物とその製造方法及び安定化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0126661B2 (es) * 1979-10-17 1989-05-24 Roquette Freres
JPH0816052B2 (ja) * 1988-11-21 1996-02-21 エスエス製薬株式会社 糖衣錠
JP3507211B2 (ja) * 1995-07-13 2004-03-15 三菱化学株式会社 糖衣液及び糖衣錠
CN1297550C (zh) * 1998-12-04 2007-01-31 武田药品工业株式会社 苯并呋喃衍生物及其制备和用途
JP2001139495A (ja) * 1999-11-19 2001-05-22 Shin Etsu Chem Co Ltd フィルムコーティング剤及び経口固形製剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
JP2002047174A (ja) * 2000-05-26 2002-02-12 Towa Chem Ind Co Ltd 無糖コーティング製剤及びその製造方法
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
JP2002179559A (ja) * 2000-10-06 2002-06-26 Takeda Chem Ind Ltd 薄層糖衣錠およびその製造方法
JP4824224B2 (ja) * 2001-08-28 2011-11-30 興和株式会社 糖衣製剤
JP2003095928A (ja) * 2001-09-27 2003-04-03 Kowa Co 糖衣製剤
JP2003113060A (ja) * 2001-10-02 2003-04-18 Lion Corp 発泡成分含有糖衣物
JP4336074B2 (ja) * 2001-11-15 2009-09-30 三菱商事フードテック株式会社 色調および食感が良好な硬質糖衣錠剤
WO2003051355A1 (en) * 2001-12-19 2003-06-26 Takeda Chemical Industries, Ltd. Solid compositions containng compounds unstable to oxygen and method for stabilization thereof
JP4590034B2 (ja) * 2002-01-31 2010-12-01 三菱商事フードテック株式会社 硬質糖衣製剤、糖衣液及び硬質糖衣製剤の製造方法
JP2004123578A (ja) * 2002-09-30 2004-04-22 Dainippon Ink & Chem Inc 糖衣錠およびその製造方法
JP2005298373A (ja) * 2004-04-08 2005-10-27 Kyowa Hakko Kogyo Co Ltd 吸水性アミノ酸含有糖衣錠剤
JP4984455B2 (ja) * 2004-08-18 2012-07-25 日本新薬株式会社 二重被覆錠剤

Also Published As

Publication number Publication date
PE20070077A1 (es) 2007-02-07
CA2610342A1 (en) 2006-12-14
KR20080014014A (ko) 2008-02-13
EP1889611A1 (en) 2008-02-20
CR9523A (es) 2008-02-04
BRPI0611058A2 (pt) 2011-02-22
RU2007145426A (ru) 2009-06-20
TW200716207A (en) 2007-05-01
MA29540B1 (fr) 2008-06-02
US20090030064A1 (en) 2009-01-29
JPWO2006132360A1 (ja) 2009-01-08
ZA200710333B (en) 2009-03-25
WO2006132360A1 (ja) 2006-12-14
NO20080175L (no) 2008-03-04
AU2006256038A1 (en) 2006-12-14
RU2407515C2 (ru) 2010-12-27
NZ563820A (en) 2010-03-26
IL187407A0 (en) 2008-02-09
CN101193625A (zh) 2008-06-04

Similar Documents

Publication Publication Date Title
AR054133A1 (es) Preparacion recubierta con azucar
ES2560901T3 (es) Preparaciones recubiertas de azúcar duro, soluciones de recubrimiento de azúcar y procedimiento para producir preparaciones recubiertas de azúcar duro
PE20081663A1 (es) Preparacion solida que comprende alogliptin y pioglitazona
AR051128A1 (es) Composiciones encapsuladas para activos, termicamente estables, altamente resistentes
PE20060425A1 (es) Formulacion de tableta revestida que comprende saxagliptina
AR053292A1 (es) Un sistema de suministro para dos o mas componentes acivos como parte de una composicion comestible
CL2014000187A1 (es) Composicion de encolado que comprende una mezcla de azucares hidrogenados que comprenden mezcla de azucares hidrogenados que comprenden al menos 25 % en peso de maltitol, clculado sobre la base de la materia seca de los azucares ghidrogenados y al menos un agente de reticulacion polifuncional; producto aislante acustico o termico; y velo de fibras minerales.
BR112012014722A2 (pt) "microcápsulas de sílica de liberação sustentada"
BR0013825A (pt) Formas de apresentação de tramadol
PE20030580A1 (es) Composiciones farmaceuticas de glibenclamida y metformina, en capas separadas
AR057708A1 (es) Estructura laminar
ATE545639T1 (de) Alkylsubstituierte tetrahydropyrane als aromastoffe
CR8428A (es) Agente endoparasiticidas para la administracion topica
AR114148A2 (es) Composición terapéutica saborizada basada en arcilla
BRPI0518869A2 (pt) agentes citotàxicos compreendendo taxanos
DK2083638T3 (da) Smagsfrigivende kerner og deres anvendelse i tyggegummi
SI2021002T1 (sl) Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
TW200616603A (en) Medical container and medical plural chamber container
WO2009138608A3 (fr) Composition stable destinee a l'assemblage demontable de substrats par collage
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
CR9259A (es) Composicion antihelmintica
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
CR9839A (es) Composicion farmaceutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpetica
JP2004026743A5 (es)
CN202810107U (zh) 一种环保复合地板

Legal Events

Date Code Title Description
FA Abandonment or withdrawal